GON4L

Chr 1AR

gon-4 like

Also known as: GON-4, GON4, LTMS, YARP

Predicted to enable transcription corepressor activity. Predicted to be involved in negative regulation of DNA-templated transcription. Predicted to act upstream of or within B cell differentiation. Located in nuclear body. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…

Primary Disease Associations & Inheritance

Li-Takada-Miyake syndromeMIM #621212
AR

Clinical highlights

Interpreting a novel variant
Loss of function is the curated mechanism (Gene2Phenotype) and the gene is intolerant of it in the population — truncating, frameshift and canonical splice variants carry more prior weight here than missense.Curated gene-level mechanism — a prior for triage, not a per-variant call.
0
Active trials
4
Pubs (1 yr)
P/LP submissions
P/LP missense
0.30
LOEUF· LoF intol.
LOF
Mechanism· G2P

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.30LOEUF
pLI 0.951
Z-score 7.13
OE 0.20 (0.140.30)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
1.65Z-score
OE missense 0.86 (0.820.91)
984 obs / 1140.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.20 (0.140.30)
00.351.4
Missense OE?0.86 (0.820.91)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 19 / 93.3Missense obs/exp: 984 / 1140.5Syn Z: -0.51

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

GON4L · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →